Facioscapulohumeral Muscular Dystrophy 3 Digenic C5561959
A rare form of muscular dystrophy affecting face and shoulder muscles. Symptoms and severity differ among individuals.
Key facts at a glance
- ICD-10
- Q79.9
- ICD-11
- LA00.0
- Body system
- musculoskeletal
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Facial weakness
(musculoskeletal)Joint pain or stiffness
(musculoskeletal)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Upper limb weakness
(musculoskeletal)Scapular winging
(musculoskeletal)Hip girdle weakness
(musculoskeletal)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Comprehensive rehabilitation program
Multidisciplinary physical therapy addressing the complex interplay of muscle weakness, fatigue, and potential contractures in digenic FSHD. Includes strengthening, stretching, and energy conservation techniques.
Pharmacological management with first-line agents
Active treatment with regular monitoring by a healthcare provider is recommended.
Additional treatment options
DMD-targeted therapeutic agents
Investigation of novel pharmacologic approaches including myostatin inhibitors and other muscle-building agents being studied in clinical trials for muscular dystrophies.
medicationPsychological support and counseling
Mental health support addressing depression, anxiety, and adjustment to progressive disability. Includes coping strategies, family counseling, and peer support connections.
psychologicalAssistive device provision and home modifications
Provision of appropriate mobility aids, orthotics, and home accessibility modifications to maximize independence and safety as disease progresses.
lifestyleCardiac surveillance program
Regular cardiac monitoring including echocardiography and ECG given the potential for cardiac involvement in muscular dystrophy patients, with frequency based on individual risk.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Facioscapulohumeral Muscular Dystrophy 3 Digenic C5561959?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Facioscapulohumeral Muscular Dystrophy 3 Digenic C5561959. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy